Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-16, Stock:JNJ, The news for the past five days is as follows:
2020-06-09: NEWS1: Roche, Johnson & Johnson Top R&D Spenders in 2019.NEWS2: Here's Why Fate Therapeutics Stock Jumped Higher Today.NEWS3: Tuesday Morning Market Highlights.NEWS4: Revlon, Chanel, L'Oréal Are Quietly Removing Talc From Their Products As Cancer Lawsuits Mount: Report.NEWS5: 3 Stocks to Help You Build Retirement Wealth.NEWS6: Edited Transcript of JNJ earnings conference call or presentation 14-Apr-20 12:30pm GMT.NEWS7: Zoom Deals Put Barbarians at the Virtual Gate.NEWS8: Exclusive: Chanel, Revlon, L'Oreal pivoting away from talc in some products.NEWS9: Exclusive: Chanel, Revlon, L'Oreal pivoting away from talc in some products.
2020-06-10: NEWS1: MARKETS: Tech stocks boost Nasdaq above 10K as Dow slumps — YF Premium is bullish on Johnson & Johnson (JNJ).NEWS2: U.S. to Conduct Phase III Trials of Virus Vaccine Candidates.NEWS3: The Federal Reserve’s actions ‘have been one of the main ingredients of recovery’: Parrish Capital.NEWS4: Stock market news live updates: Stocks trade choppily after Fed decision.NEWS5: Coronavirus update: Reopenings continue as virus counts spike in key states; J&J ramps up vaccine push.NEWS6: Fauci: Sped-up production on coronavirus vaccine risky and costly — but worth it.NEWS7: J&J Brings Human Trial Start Of Its Covid-19 Vaccine Forward To July.NEWS8: Coronavirus update: Global death toll passes 412,000, as Dr. Fauci warns that COVID-19 is far from over.NEWS9: Johnson & Johnson to Begin Coronavirus Vaccine Clinical Trial in July.NEWS10: Pivotal U.S. COVID-19 vaccine trials to begin in July.NEWS11: Johnson & Johnson accelerates initiation of human trial of COVID-19 virus vaccine.NEWS12: Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July.
2020-06-11: NEWS1: ‘Trump time’: Peter Navarro says the manufacturing of a coronavirus vaccine will be swift.NEWS2: Coronavirus update: U.S. case tally passes 2 million mark and 21 states are still seeing increases in infections.NEWS3: Yahoo Finance Presents: White House Director of Trade and Manufacturing Policy Peter Navarro.NEWS4: Coronavirus update: US reopening dogged by fears of new wave as pharma presses on with vaccine.NEWS5: Hedge Funds' 25 Top Blue-Chip Stocks to Buy Now.NEWS6: AstraZeneca's R&D Spending Spikes 21% to Industry Best in 2019.NEWS7: J&J to Begin Human Study on Coronavirus Vaccine in July.NEWS8: Moderna Will Start Testing Its Covid-19 Vaccine on 30,000 People in July.NEWS9: Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July.
2020-06-12: NEWS1: JNJ Stock Sticks to Breakeven After Band-Aid Update.NEWS2: Stock Market Crash: Where to Invest Your Money Now.NEWS3: COVID-19 cases surge, officials issue warnings.NEWS4: J&J exec: Our coronavirus vaccine is aiming for a 70% success rate in trials.NEWS5: EU urges joint efforts by bloc's states to buy COVID-19 vaccines.
2020-06-15: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: UK funds human trials of potential COVID-19 vaccine from Imperial.NEWS3: A Snapshot Of The COVID-19 Data Sharing Ecosystem.NEWS4: Top Research Reports for Johnson & Johnson, Walmart & Bank of America.NEWS5: Germany investing in coronavirus vaccine maker that it accused the Trump administration of trying to poach.NEWS6: Billions or trillions: The great coronavirus trade-off.NEWS7: 3 Rock Solid Dividend Stocks That Won't Flinch if the Market Crashes Again.

Answer: Rise